It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

pharmaceuticals

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Japan turns to antibody cocktails as 'new weapon' in fight against pandemic

National | FOCUS Aug 24, 2021

Japan turns to antibody cocktails as 'new weapon' in fight against pandemic

by Tomohiro Osaki

The government has widened the use of the drug Ronapreve, but some doctors say it needs to go further and make it available to patients isolating at home too.

Can Moderna buy its way into the $200 billion club?

Commentary / World Aug 12, 2021

Can Moderna buy its way into the $200 billion club?

by Max Nisen

Moderna's COVID-19 windfall sees its market valuation surged by more than $100 billion since May.

Japan backs 'revolutionary' COVID-19 drug Ronapreve to help tame crisis

National Aug 11, 2021

Japan backs 'revolutionary' COVID-19 drug Ronapreve to help tame crisis

by Osamu Tsukimori

The antibody cocktail, intended for mildly and moderately ill patients, could in the near future be used to treat those quarantining at home, helping to ease the strain on hospitals.

Japan drugmaker Shionogi to seek approval for oral COVID-19 drug

National Aug 6, 2021

Japan drugmaker Shionogi to seek approval for oral COVID-19 drug

Designed to prevent moderate COVID-19 symptoms from worsening, the drug could facilitate at-home treatment and ease the strain on hospitals.

SoftBank built a $5 billion stake in pharma giant Roche

Business / Corporate Aug 4, 2021

SoftBank built a $5 billion stake in pharma giant Roche

by Giles Turner and Tom Giles

Roche's diagnostics unit reacted swiftly to the pandemic, and now sales are boosted by its COVID-19 testing business.

Legitimate pain research is more crucial than ever

Commentary / World Jul 30, 2021

Legitimate pain research is more crucial than ever

by Faye Flam

Researchers today say opioids are not only dangerous; they are not a good long-term solution for chronic pain sufferers. The relief tends to wane with time.

Even with delta surging, experts say two vaccine doses is enough for now

National Jul 29, 2021

Even with delta surging, experts say two vaccine doses is enough for now

by Osamu Tsukimori

U.S. firm Pfizer Inc. has called for an additional third shot of its COVID-19 vaccine, citing new data showing its efficacy tails off after six months.

Global quest underway to speed up COVID-19 vaccine trials

World / Science & Health | FOCUS Jul 21, 2021

Global quest underway to speed up COVID-19 vaccine trials

by Julie Steenhuysen and Ludwig Burger

Researchers are trying to determine just what level of antibodies a vaccine must produce to provide protection against the illness.

World carved up into haves and have-nots by mRNA vaccine access

World | FOCUS Jul 16, 2021

World carved up into haves and have-nots by mRNA vaccine access

by Bruce Einhorn

The cutting-edge technology, which made its debut during the pandemic, has proven more effective than any other in staving off infections and serious illness from the coronavirus.

Pfizer outlines booster plans while regulators signal caution

World Jul 9, 2021

Pfizer outlines booster plans while regulators signal caution

Pfizer Inc. plans to request U.S. emergency authorization in August for a third booster dose of its COVID-19 vaccine.

Countries using Chinese-made vaccines and AstraZeneca increasingly eye boosters

World Jul 9, 2021

Countries using Chinese-made vaccines and AstraZeneca increasingly eye boosters

Officials are being motivated by concerns that delta and other variants appear to be breaking down defenses of vaccines not made from the supereffective messenger RNA technology.

Fujifilm says pivot to health care and chips paid off in pandemic

Business / Corporate Jul 9, 2021

Fujifilm says pivot to health care and chips paid off in pandemic

by Lisa Du and Grace Huang

Over the past decade, Fujifilm parlayed its expertise in film and chemicals to move into medical diagnostics, pharmaceutical manufacturing and supplying materials to chipmakers.

« 1 … 11 12 13 … 42 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times